Spinal Cord Stimulation Combined With Exercise in Persistent Spinal Pain Syndrome

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorFundación Universidad Católica de Valencia San Vicente Mártir

About this trial

Introduction. At the neurophysiological level, it is possible to observe an increase in the central processing of pain in patients diagnosed with persistent Spinal Pain Syndrome (PSPS-T1/2), potentially stemming from dysfunctions in the endogenous facilitation and inhibition of pain. Administration of high doses of spinal cord stimulation to individuals with PSPS-T1/2 may induce supraspinal descending activation. Similarly, exercise is recognized as a fundamental aspect of spinal pain management. Studies have demonstrated its impact on neurophysiological factors, including the release of spinal and supraspinal beta-endorphins, which activate μ-opioid receptors. Therefore, the purpose of this study will be to examine the effect of SCS in combination with lumbo-pelvic stability core training on perceived low back pain, quality of life and disability in failed back surgery syndrome (FBSS) patients. Methods/Materials. A double-blind randomized clinical trial (RCT) has been designed. All participants will be randomized from a pre-set sequence. The intervention design has been elaborated from the CONSORT guidelines. This study protocol has been approved by the Ethics Committee in research of Salamanca Health Area (protocol number PI 2023 101435 in (24/01/2024) in accordance with the ethical guidelines of the Helsinki declaration. Sample size was calculated using G Power® Sample size software (University of Düsseldorf). The calculation was based on a moderate effect size of 0.4 (partial η2 = 0.40, α = .05, power = 0.90), resulting in a total of 28 patients. Assuming a 30% dropout rate, 36 participants will be recruited in total. Two sessions per week will be scheduled for 8 weeks with a total of 16 sessions. Each work session will have a duration of 60 minutes. The exercise will be adapted according to the phases based on the results already published, limiting in each phase the degrees of flexion and extension of the spine in order to avoid the risk of electrode migration. Primary outcomes will be functionality, satisfaction, strength, psychosocial variables, quality of life and pain perception.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Have a diagnostic of PSPS-T1/2 with leg pain and back pain,

Patients older than 18 years

6 months with pain

Visual Analogue Scale score >7

Disqualifiers

Previous surgeries in abdominal area

Pregnant or lactating

Severe fractures or pathologies

Spine structural deformity

Trial design

Design model

Parallel

Treatments tested in this trial

  • Exercise

    Procedure/Surgery

    The exercise The exercise will be adapted according to the phases based on the results already published, limiting in each phase the degrees of flexion and extension of the spine in order to avoid the risk of electrode migration.

  • Spinal Cord Stimulation

    Procedure/Surgery

    Spinal cord stimulation (SCS) involves an implantable pulse generator with the potential for enhanced therapeutic success through stimulation algorithms and parameters (28). Spinal cord stimulation (SCS) targeting distal areas, such as the dorsal root ganglion, may offer greater anatomical specificity in therapy

Treatment groups

36 Participants
are divided into 2 treatment groups
Group A: Spinal Cord StimulationActive comparator 1 intervention
Group B: Spinal Cord Stimulation+ExerciseExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Disability (Oswestry Disability Index)

The Oswestry Disability Index (ODI) is the most used and validated assessment test for lumbar pain. Is a self-assessment test divided in ten sections designed to assess the limitations in daily life

Time frame
at baseline, Post3weeks, Post2months, Post6months
2

Perception Pain (Visual analogue scale)

This scale is an efficient tool to quantify in a subjective and selective way this range in which 0 is considered a total absence of pain and 10 the worst pain imaginable

Time frame
at baseline, Post3weeks, Post2months, Post6months

Secondary outcomes

1

Quality of life (Short Form 36 Health Survey, SF36)

The measures the quality of life and comprises several dimensions: (a) physical functioning, (b) role physical, (c) role emotional, (d) social functioning, (e) bodily pain and (f) vitality. Scores for each component summary are calculated based on responses to the twelve items, with higher scores indicating better health-related quality of life.

Time frame
at baseline, Post3weeks, Post2months, Post6months
2

Patient's satisfaction

There are already published studies about diagnosed patients that evaluate their satisfaction using a numeric scale of 11 (-5 to 5) (37,38). High scores show the patient's satisfaction with the treatment.

Time frame
at baseline, Post3weeks, Post2months, Post6months
3

Strength (Sorensen Test)

Sorensen test it measures the amount of strength and resistance of the back extensors

Time frame
at baseline, Post3weeks, Post2months, Post6months
4

Fear of Movement (Tampa Scale of Kinesiophobia, TSK)

The Tampa Scale of Kinesiophobia (TSK) was used to measure fear of movement or reinjury. Scores on the TSK are calculated by summing responses to individual items, with higher scores indicating greater levels of kinesiophobia. The scale has been validated and widely used in research and clinical settings to assess and monitor fear of movement in individuals with chronic pain conditions, musculoskeletal injuries, and other conditions where fear of movement may impact rehabilitation or daily functioning.

Time frame
at baseline, Post3weeks, Post2months, Post6months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Fundación Universidad Católica de Valencia San Vicente Mártir

Lead sponsor

Instituto de Investigación Biomédica de Salamanca

Collaborator